Citation Impact
Citing Papers
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement
2015 Standout
Reporting methods in studies developing prognostic models in cancer: a review
2010
Cancer statistics, 2017
2017 Standout
Cancer statistics, 2020
2020 Standout
Cancer statistics, 2018
2018 Standout
Cancer Statistics, 2021
2021 Standout
Mechanisms, regulation and functions of the unfolded protein response
2020 Standout
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
2010 Standout
Inventory of prostate cancer predictive tools
2008
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 Standout
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
2017 Standout
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
2008 Standout
Short‐ and long‐term complications of open radical prostatectomy according to the Clavien classification system
2008
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
2009 Standout
Interdependent IL-7 and IFN-γ signalling in T-cell controls tumour eradication by combined α-CTLA-4+α-PD-1 therapy
2016 StandoutNobel
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
2017 Standout
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
2014 StandoutNature
First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study
2017 Standout
Comparison of Conventional-Dose vs High-Dose Conformal Radiation Therapy in Clinically Localized Adenocarcinoma of the Prostate
2005 Standout
Deep learning-based survival prediction for multiple cancer types using histopathology images
2020
Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer
2013
Asthma
2017 Standout
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Prevalence and Correlates of Sexual Dysfunction in Men and Women With Type 2 Diabetes
2014
Survival Following Primary Androgen Deprivation Therapy Among Men With Localized Prostate Cancer
2008
Outcomes of Localized Prostate Cancer Following Conservative Management
2009
Sexual dysfunction and infertility as late effects of cancer treatment
2014
Cancer statistics for Hispanics/Latinos, 2012
2012
Smoking cessation during alcohol treatment: a randomized trial of combination nicotine patch plus nicotine gum
2009
Bladder cancer
2016 Standout
Deep learning in histopathology: the path to the clinic
2021 Standout
Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial
2016 Standout
Androgen Deprivation Therapy for Localized Prostate Cancer and the Risk of Cardiovascular Mortality
2007
Regulation and Function of the PD-L1 Checkpoint
2018 Standout
High-dose nicotine patch therapy for smokers with a history of alcohol dependence: 36-week outcomes
2006
Determinants of erectile dysfunction in type 2 diabetes
2010
Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error
2014
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Molecular Targets for Diabetes Mellitus-associated Erectile Dysfunction
2009
Reporting performance of prognostic models in cancer: a review
2010
Literacy, race, and PSA level among low-income men newly diagnosed with prostate cancer
2006
Management strategies for gastrointestinal, erectile, bladder, and sudomotor dysfunction in patients with diabetes
2011
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
2010 Standout
The Clavien-Dindo Classification of Surgical Complications
2009 Standout
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
2015 Standout
Obstructive sleep apnoea and its cardiovascular consequences
2008 Standout
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
2017 Standout
Nicotine replacement therapy for smoking cessation
2012 Standout
How To Build and Interpret a Nomogram for Cancer Prognosis
2008 Standout
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
2012 Standout
Decisional conflict in economically disadvantaged men with newly diagnosed prostate cancer: Baseline results from a shared decision‐making trial
2014
Self-management approaches for people with chronic conditions: a review
2002 Standout
American Cancer Society prostate cancer survivorship care guidelines
2014
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Bladder Cancer
2020 Standout
Development of a stress response therapy targeting aggressive prostate cancer
2018
Diabetes and Cancer
2010 Standout
Decision aids for people facing health treatment or screening decisions
2017 Standout
British Guideline on the Management of Asthma
2008
Prostate Specific Antigen Best Practice Statement: 2009 Update
2009
A Meta-analysis of Diabetes Mellitus and the Risk of Prostate Cancer
2006
Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments
2010 Standout
Low Health Literacy and Health Outcomes: An Updated Systematic Review
2011 Standout
Cancer treatment and survivorship statistics, 2016
2016 Standout
The future of immune checkpoint therapy
2015 StandoutScienceNobel
Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicities
2016 StandoutNobel
Defining High Risk Prostate Cancer With Risk Groups and Nomograms: Implications for Designing Clinical Trials
2006
Bioorthogonal Labeling of Human Prostate Cancer Tissue Slice Cultures for Glycoproteomics
2017 StandoutNobel
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
Diabetic Neuropathy: A Position Statement by the American Diabetes Association
2016 Standout
Erectile Dysfunction in Diabetes Mellitus
2009
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): The TRIPOD Statement
2015 Standout
Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
2008 Standout
THE CONTEMPORARY MANAGEMENT OF PROSTATE CANCER IN THE UNITED STATES: LESSONS FROM THE CANCER OF THE PROSTATE STRATEGIC UROLOGIC RESEARCH ENDEAVOR (CAPSURE), A NATIONAL DISEASE REGISTRY
2004
Interventions for educating children who are at risk of asthma-related emergency department attendance
2009
Patterns of Repeat Prostate Biopsy in Contemporary Clinical Practice
2014
Comparison of MR/Ultrasound Fusion–Guided Biopsy With Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer
2015 Standout
Low suspicion lesions on multiparametric magnetic resonance imaging predict for the absence of high‐risk prostate cancer
2012
Works of David Latini being referenced
Androgen‐deprivation therapy as primary treatment for localized prostate cancer
2006
Education of Parents of Infants and Very Young Children with Asthma: A Developmental Evaluation of the Wee Wheezers Program
1996
Differences in clinical characteristics and disease‐free survival for Latino, African American, and non‐Latino white men with localized prostate cancer
2006
History of Diabetes, Clinical Features of Prostate Cancer, and Prostate Cancer Recurrence-Data from CaPSURETM (United States)
2005
Cisplatin-Ineligible and Chemotherapy-Ineligible Patients Should Be the Focus of New Drug Development in Patients With Advanced Bladder Cancer
2013
Education predicts quality of life among men with prostate cancer cared for in the department of Veterans affairs
2007
Impact of comorbidity on health-related quality of life in men undergoing radical prostatectomy: Data from CaPSURE
2006
Sexual Side Effects and Prostate Cancer Treatment Decisions
2009
Predicting disease recurrence in intermediate and high-risk patients undergoing radical prostatectomy using percent positive biopsies: results from CaPSURE
2002
Perception of cancer and inconsistency in medical information are associated with decisional conflict: a pilot study of men with prostate cancer who undergo active surveillance
2011
TREATMENT OF PATIENTS WITH HIGH RISK LOCALIZED PROSTATE CANCER: RESULTS FROM CANCER OF THE PROSTATE STRATEGIC UROLOGICAL RESEARCH ENDEAVOR (CaPSURE)
2005
A controlled smoking cessation trial for substance-dependent inpatients.
2001
The Relationship Between Anxiety and Time to Treatment for Patients With Prostate Cancer on Surveillance
2007
Is Ethnicity an Independent Predictor of Prostate Cancer Recurrence After Radical Prostatectomy?
2002
THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CANCER OF THE PROSTATE RISK ASSESSMENT SCORE: A STRAIGHTFORWARD AND RELIABLE PREOPERATIVE PREDICTOR OF DISEASE RECURRENCE AFTER RADICAL PROSTATECTOMY
2005
Is ethnicity an independent predictor of prostate cancer recurrence after radical prostatectomy?
2002
Predicting Recurrence After Radical Prostatectomy for Patients With High Risk Prostate Cancer
2003
Predicting recurrence after radical prostatectomy for patients with high risk prostate cancer.
2003
Do Impotent Men With Diabetes Have More Severe Erectile Dysfunction and Worse Quality of Life Than the General Population of Impotent Patients?
2003
Patterns of chemotherapy and survival in elderly patients with advanced bladder cancer: A large Medicare database study.
2013